BIOCRYST PHARMACEUTICALS INC shareholders Q3 2023

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

BIOCRYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CANADA PENSION PLAN INVESTMENT BOARD 113,800$805,7040.00%
CarsonAllaria Wealth Management, Ltd. 230$1,6280.00%
MORGAN STANLEY 1,825,824$12,926,8340.00%
UBS Group AG 305,951$2,166,1330.00%
Bank of New York Mellon Corp 767,571$5,434,4030.00%
COMMERCE BANK 19,560$138,4840.00%
Handelsbanken Fonder AB 35,500$2510.00%
Kestra Advisory Services, LLC 18,779$132,9550.00%
NEW YORK STATE COMMON RETIREMENT FUND 76,896$5440.00%
COMERICA BANK 27,094$191,8260.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 1,300$9,2040.00%
BANK OF AMERICA CORP /DE/ 1,091,518$7,727,9470.00%
J.P. Morgan Private Wealth Advisors LLC 30,603$216,6690.00%
Legal & General Group Plc 385,782$2,731,3360.00%
Citadel Advisors 547,300$3,874,8840.00%
CANADA LIFE ASSURANCE Co 62,144$4390.00%
Walleye Capital LLC 70,100$496,3080.00%
Walleye Trading LLC 15,800$111,8640.00%
Walleye Trading LLC 9,956$70,4880.00%
ROYAL BANK OF CANADA 57,641$408,0000.00%
External links

This page lists BIOCRYST PHARMACEUTICALS INC's shareholders in Q3 2023. To view BIOCRYST PHARMACEUTICALS INC's shareholder history, click here.